2024-10-15 – Press Releases – www.prnewswire.com
Achieving a Significant Clinical Milestone in Assessing the ReCET System as a Groundbreaking Treatment for Type 2 Diabetes MINNEAPOLIS, Oct. 15, 2024 /PRNewswire/ — Endogenex, Inc., a clinical-stage medical device company focused on improving outcomes for patients with type 2 diabetes…